Ginkgo Bioworks Holdings (DNABW) Shares Outstanding (Diluted Average) (2019 - 2025)

Ginkgo Bioworks Holdings (DNABW) reported Shares Outstanding (Diluted Average) of $55.5 million for Q4 2025, up 6.87% on a YoY basis from $51.9 million in Q4 2024, and up 0.99% quarter-over-quarter from $54.9 million in Q3 2025.

Ginkgo Bioworks Holdings (DNABW) Shares Outstanding (Diluted Average) (2019 - 2025) Analysis & Trends

Ginkgo Bioworks Holdings has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $55.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 6.87% year-over-year to $55.5 million; the trailing twelve-month figure through Dec 2025 stood at $55.5 million (up 6.87% YoY), and the FY2025 full-year result was $55.5 million, up 6.87% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 stood at $55.5 million, up from $54.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $1.9 billion in Q2 2023, with the low at $1.6 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $611.6 million across 5 years, with a median of $54.6 million in 2025.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) soared 119130.92% — and 2024, when it slumped 97.38%.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) stood at $1.4 billion in 2021, then plunged by 96.91% to $42.0 million in 2022, then increased by 15.75% to $48.6 million in 2023, then grew by 6.76% to $51.9 million in 2024, then grew by 6.87% to $55.5 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $55.5 million (Q4 2025), $54.9 million (Q3 2025), and $54.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Ginkgo Bioworks Holdings - - 16.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 55.46 Mn
Sep 30, 2025 54.92 Mn
Jun 30, 2025 54.55 Mn
Mar 31, 2025 54.24 Mn
Dec 31, 2024 51.89 Mn
Sep 30, 2024 51.25 Mn
Jun 30, 2024 50.75 Mn
Mar 31, 2024 50.13 Mn
Dec 31, 2023 48.61 Mn
Sep 30, 2023 48.33 Mn
Jun 30, 2023 1.93 Bn
Mar 31, 2023 1.92 Bn
Dec 31, 2022 42.00 Mn
Sep 30, 2022 1.63 Bn
Jun 30, 2022 1.62 Bn
Mar 31, 2022 1.61 Mn
Dec 31, 2021 1.36 Bn
Sep 30, 2021 1.30 Bn
Jun 30, 2021 1.29 Bn
Dec 31, 2020 1.27 Bn